Back to Search
Start Over
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
- Source :
- The Lancet; January 2022, Vol. 399 Issue: 10323 p461-472, 12p
- Publication Year :
- 2022
-
Abstract
- A range of safe and effective vaccines against SARS CoV 2 are needed to address the COVID 19 pandemic. We aimed to assess the safety and efficacy of the COVID-19 vaccine SCB-2019.
Details
- Language :
- English
- ISSN :
- 01406736 and 1474547X
- Volume :
- 399
- Issue :
- 10323
- Database :
- Supplemental Index
- Journal :
- The Lancet
- Publication Type :
- Periodical
- Accession number :
- ejs58781927
- Full Text :
- https://doi.org/10.1016/S0140-6736(22)00055-1